New Guidelines Address Outpatient Parental Antimicrobial Therapy
November 13th 2018An infectious diseases (ID) specialist should be consulted before patients receive intravenous (IV) antimicrobial infusion therapy outside of the hospital, suggest updated guidelines released by the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Diseases.
Patient Engagement Solutions for Medication Nonadherence in Older Adults
November 12th 2018Patient nonadherence to prescribed medications is associated with poor therapeutic outcomes, progression of disease, increased healthcare utilization, and an estimated burden of billions per year in avoidable direct healthcare costs.
FDA Officials Approve Revefenacin for Maintenance Treatment of COPD
November 9th 2018Officials with the FDA have approved Theravance Biopharma and Mylan’s revefenacin (Yupelri) inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), according to a press release.1
FDA Officials Approve Ebola Fingerstick Test with Portable Reader
November 9th 2018Officials with the US FDA this week announced an emergency use authorization (EUA) for a rapid, single-use test for the detection of Zaire ebolavirus, making it the second Ebola rapid antigen fingerstick test available under EUA, but the first that uses a portable battery-operated reader.
Label Causing Delay in Accessing Epinephrine for Some EpiPen Users
November 2nd 2018The FDA has issued a warning to patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, as well as authorized generic versions, may block access to the auto-injector.
First DTC Genetic Test for Medication Metabolism Receives FDA Boost
November 1st 2018Officials with the US FDA this week permitted marketing, with special controls, of the 23andMe Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient’s ability to metabolize some medications better than others.
FQ Safety Label Updated to Highlight Risk of Blood Glucose Issues, Psychiatric Reactions
October 26th 2018The US Food and Drug Administration (FDA) is reminding health care professionals who prescribe and dispense antibiotics that there are recent safety labeling changes for systemic fluoroquinolones.
World is Challenged by U.S. to Fight Antibiotic Resistance
September 26th 2018Unprecedented in scale, the AMR Challenge charges pharmaceutical and health insurance companies, food animal producers and purchasers, medical professionals, government health officials, and other industry leaders from around the world to work together to address antibiotic resistance.